SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001561743-14-000010
Filing Date
2014-03-14
Accepted
2014-03-14 15:52:56
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-K kindredbio10-k.htm 10-K 1343441
2 EXHIBIT 23.1 exhibit231auditorconsent.htm EX-23.1 3514
3 EXHIBIT 31.1 exhibit311.htm EX-31.1 11793
4 EXHIBIT 31.2 exhibit312.htm EX-31.2 11808
5 EXHIBIT 32.1 exhibit321.htm EX-32.1 4924
6 EXHIBIT 32.2 exhibit322.htm EX-32.2 5581
7 diacerintable.jpg GRAPHIC 44298
8 fexofenadinetable2.jpg GRAPHIC 32891
9 fexofenadinetable.jpg GRAPHIC 43073
10 painintensity.jpg GRAPHIC 22529
11 pipelinechart.jpg GRAPHIC 268948
12 stockchart.jpg GRAPHIC 106289
  Complete submission text file 0001561743-14-000010.txt   2096569
Mailing Address 58 WEST PORTAL AVE., #105 SAN FRANCISCO CA 94127
Business Address 58 WEST PORTAL AVE., #105 SAN FRANCISCO CA 94127 415-596-1557
Kindred Biosciences, Inc. (Filer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36225 | Film No.: 14694415
SIC: 2834 Pharmaceutical Preparations